0001763950-19-000004.txt : 20190318 0001763950-19-000004.hdr.sgml : 20190318 20190318162000 ACCESSION NUMBER: 0001763950-19-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190318 DATE AS OF CHANGE: 20190318 EFFECTIVENESS DATE: 20190318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lantern Pharma Inc. CENTRAL INDEX KEY: 0001763950 IRS NUMBER: 463973463 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-335101 FILM NUMBER: 19688472 BUSINESS ADDRESS: STREET 1: 1920 MCKINNEY AVENUE STREET 2: 7TH FLOOR CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 9177517141 MAIL ADDRESS: STREET 1: 1920 MCKINNEY AVENUE STREET 2: 7TH FLOOR CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: Lantern Pharma DATE OF NAME CHANGE: 20190108 D 1 primary_doc.xml X0708 D LIVE 0001763950 Lantern Pharma Inc. 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX TEXAS 75201 9177517141 TEXAS Lantern Pharma Corporation true Panna Sharma 1920 McKinney Avenue 7th Floor Dallas TX TEXAS 75201 Executive Officer Director David Silberstein 1920 McKinney Avenue 7th Floor Dallas TX TEXAS 75201 Director Donald Keyser 1920 McKinney Avenue 7th Floor Dallas TX TEXAS 75201 Director John Fucci 1920 McKinney Avenue 7th Floor Dallas TX TEXAS 75201 Director Arunkumar Asaithambi 1920 McKinney Avenue 7th Floor Dallas TX TEXAS 75201 Director Biotechnology Decline to Disclose 06b false 2019-03-07 false true true true false 0 6289287 2385005 3904282 This amount consists of proceeds from the sale of Series A Preferred Stock, the sale of securities convertible into Series A Preferred Stock and future proceeds which may be realized from the exercise of warrants issued in connection with this offering. false 5 0 0 360000 true Portions of the proceeds will be used to make ordinary course compensation payments to the Company's employees, including the Company's CEO. false Lantern Pharma Inc. Panna Sharma Panna Sharma CEO 2019-03-18